.png)
FDA plans to end animal testing requirements for monoclonal antibody drugs
The FDA announced on April 10 that the agency plans to end the requirement for new monoclonal antibodies and some other drugs to be tested in animals. Animal testing will be replaced with a suite of techniques, including computational models and human cell lines and organoids, the agency said.
The FDA announced on April 10 that the agency plans to end the requirement for new monoclonal antibodies and some other drugs to be tested in animals. Animal testing will be replaced with a suite of techniques, including computational models and human cell lines and organoids, the agency said.
